Philips carries a market cap of approximately €15 billion ($16 billion USD) as of early 2026, trading on Euronext Amsterdam under PHIA. The Dutch health technology company's valuation has fallen sharply from a 2021 peak of €43 billion, weighed down by the multi-billion-dollar sleep apnea device recall and ongoing margin pressure from remediation costs.
Market Cap Of Philips
Market cap in USD equivalent from Amsterdam Stock Exchange listing (1912) through 2026. EUR/USD conversion at approximate annual average rates. Consumer electronics era peak (2000) and health technology peak (2021) visible.
Year-On-Year Philips Market Cap
| Year | Market Cap (USD equiv.) | YoY Change |
|---|---|---|
| 2016 | $22.8B | — |
| 2017 | $30.4B | +33.3% |
| 2018 | $28.0B | −7.9% |
| 2019 | $38.8B | +38.6% |
| 2020 | $46.4B | +19.6% |
| 2021 | $43.2B | −6.9% |
| 2022 | $18.8B | −56.5% |
| 2023 | $16.4B | −12.8% |
| 2024 | $14.8B | −9.8% |
| 2025 | $16.0B | +8.1% |
Note: USD equivalents converted from EUR at approximate annual average exchange rates. The 2022 collapse reflects the sleep apnea device recall announced in June 2021. Philips has divested most non-healthcare businesses since 2016 and now operates as a pure-play health technology company.